Startup Exit Awards 2019: Galera Therapeutics makes history with $150M Series C raise

St. Louis Business Journal

May 17, 2019

Clinical-stage drug discovery startup Galera Therapeutics set a new benchmark last year when it raised $150 million in a Series C financing and royalty purchase agreement.